Diabetes focused startup Wellthy Therapeutics has secured $4.2 Mn or INR 30.33 crore in a pre-series A funding round. The capital infusion round was spearheaded by Samaa Capital, a VC firm specializing in early-stage investment. No other investor or investment firm participated in the funding round.
Wellthy, which is based in Mumbai, had to wait…
